var data={"title":"Vitamin B1 (thiamine): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Vitamin B1 (thiamine): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/7040?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=vitamin-b1-thiamine-drug-information\" class=\"drug drug_general\">see &quot;Vitamin B1 (thiamine): Drug information&quot;</a> and <a href=\"topic.htm?path=vitamin-b1-thiamine-patient-drug-information\" class=\"drug drug_patient\">see &quot;Vitamin B1 (thiamine): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226752\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Betaxin</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062567\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Nutritional Supplement</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Vitamin, Water Soluble</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11445204\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">\n      <b>Note:</b> Dosing presented in mcg/kg, mg/kg, and mg/day; use precaution.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Enteral daily recommendation; adequate intake</b> (Vanek 2012): Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Premature neonates: 180 to 240 mcg/kg/day </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Term neonates: 0.2 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Parenteral nutrition, maintenance requirement of thiamine</b> (Vanek 2012): IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Premature neonates:  200 to 350 mcg/kg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Term neonates: 1.2 mg/day </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062560\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=vitamin-b1-thiamine-drug-information\" class=\"drug drug_general\">see &quot;Vitamin B1 (thiamine): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: <b>Note:</b>  Dosing presented in mcg/kg, mg/kg, and mg/day; use precaution.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Adequate intake:</b> Oral: Infants: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">1 to 6 months: 0.2 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">7 to 12 months: 0.3 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Recommended daily allowance (RDA):</b> Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">1 to 3 years: 0.5 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">4 to 8 years: 0.6 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">9 to 13 years: 0.9 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">14 to 18 years: </p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Male: 1.2 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Female: 1 mg/day </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Parenteral nutrition, maintenance requirement</b> (Vanek 2012): Limited data available: IV:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants: 0.35 to 0.5 mg/kg/day; maximum daily dose: 1.2 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children: 1.2 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Thiamine deficiency (beriberi); treatment (critically ill):  </b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants: Various regimens reported: Initial: IV: 25 to 50 mg  once, followed by 10 mg IM once daily for a week then 3 to 5 mg orally once daily for at least 6 weeks (WHO 1999). Other regimens with higher initial doses have also been reported. One study used an oral dose of 100 mg/day given as 25 mg, 25 mg, and 50 mg doses administered 30 minutes apart for 3 days (Coats 2012). Another study administered 30 mg orally once daily for 20 days (Barennes 2015). <b>Note:</b> If patient is being breast-fed, the mother should also be considered for thiamine deficiency treatment (Bowman 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children: Limited data available: IM, IV: 10 mg once daily for the first week (if critically ill), then 3 to 5 mg orally once daily for at least 6 weeks (Kliegman 2016)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Adolescents: Limited data available: IM, IV: 100 mg once daily for up to 7 days (if critically ill), then 10 mg orally once daily. Dosing based on several case reports (n=3, age 14 to 17 years) of beriberi treatment after gastric bypass surgery (Towbin 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Recommended daily allowance (RDA):</b> Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">&ge;19 years: Females: 1.1 mg/day; Males: 1.2 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Pregnancy, lactation: 1.4 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Parenteral nutrition supplementation:</b> IV:  6 mg/day; may be increased to 25 to 50 mg/day with history of alcohol abuse</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Thiamine deficiency (beriberi):</b> 5 to 30 mg/dose IM or IV 3 times daily (if critically ill); then orally 5 to 30 mg/day in single or divided doses 3 times daily for 1 month </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Alcohol withdrawal syndrome:</b> 100 mg/day IM or IV for several days, followed by 50 to 100 mg/day orally</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Wernicke's encephalopathy:</b> Treatment: Initial: 100 mg IV, then 50 to 100 mg/day IM or IV until consuming a regular, balanced diet. However, larger doses may be required based on failure of lower doses to produce clinical improvement in some patients. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226731\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 50 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mg/mL (2 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 50 mg, 100 mg, 250 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral, as hydrochloride [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226717\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062571\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Oral: May administer with or without food (IOM 1998)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Parenteral: May be administered by IM or IV injection. For IV administration, various rates of administration have been reported (eg, 100 mg over 5 minutes in adults). An extended infusion time is preferred for doses &ge;100 mg. Local injection reactions may be minimized by slow administration (~30 minutes) into larger, more proximal veins. Thiamine should be administered prior to parenteral glucose solutions to prevent precipitation of acute symptoms of thiamine deficiency in the poorly nourished.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226745\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Injection: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Protect from light.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062570\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection: Infantile beriberi (FDA approved in infants); treatment of thiamine deficiency including beriberi, Wernicke's encephalopathy syndrome, and neuritis of pregnancy (All indications: FDA approved in adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral: Dietary supplement (OTC products: FDA approved in adults) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226798\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Thiamine may be confused with Tenormin, Thalomid, Thorazine</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Doxal [Brazil] may be confused with Doxil brand name for doxorubicin [U.S.]</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Doxal: Brand name for pyridoxine/thiamine [Brazil], but also the brand name for doxepin [Finland]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226796\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse reactions reported with injection.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Flushing sensation, restlessness</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Diaphoresis, pruritus, skin sclerosis (at the injection site following IM administration), urticaria</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Nausea</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hematologic &amp; oncologic: Hemorrhage (into the gastrointestinal tract)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity: Anaphylaxis (following IV administration), angioedema, hypersensitivity reaction (following IV administration)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Local: Tenderness at injection site (following IM administration)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular &amp; skeletal: Weakness</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Respiratory: Cyanosis, pharyngeal edema, pulmonary edema</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226737\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to thiamine or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226721\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity reactions: Have been reported following repeated parenteral doses; consider skin test in individuals with history of allergic reactions.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Dextrose: Administration of dextrose may precipitate acute symptoms of thiamine deficiency; use caution when thiamine status is marginal or suspect.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register 2002).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Parenteral administration: Use with caution with parenteral route (especially IV) of administration.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Vitamin deficiency: Single vitamin deficiency is rare; evaluate for other deficiencies.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300131\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6223291\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12833&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226747\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ethanol: May decrease thiamine absorption. Management: Higher doses may be needed in patients with history of ethanol abuse.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Food: High carbohydrate diets may increase thiamine requirement.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226728\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">A (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3423333\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;\">Water soluble vitamins cross the placenta. Thiamine requirements are increased in during pregnancy (IOM 1998).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Pregnant females are at increased risk of thiamine deficiency when prolonged nausea and vomiting (including hyperemesis gravidarum) occurs; deficiency may present as a polyneuropathy or Wernicke encephalopathy (Chiossi 2006; Karjalainen 1965; WHO 1999).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Thiamine supplementation is recommended in pregnant females with prolonged vomiting. Initial treatment with IV thiamine is needed when Wernicke encephalopathy is suspected. Oral, IM, or IV therapy may be considered depending on severity of thiamine deficiency (Berdai 2016; Chiossi 2006; Palacios-Marqu&eacute;s 2012). When intravenous hydration is used in the management of hyperemesis gravidarum, thiamine should be administered prior to infusing dextrose to prevent Wernicke encephalopathy (ACOG 189 2018).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062569\" class=\"block rer drugH1Div\"><span class=\"drugH1\">Reference Range</span>\n    <p style=\"text-indent:0em;display:inline\">Normal values: 1.6 to 4 mg/dL</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226720\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">An essential coenzyme in carbohydrate metabolism by combining with adenosine triphosphate to form thiamine pyrophosphate</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226736\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Oral: Adequate; IM: Rapid and complete </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Highest concentrations found in brain, heart, kidney, liver</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: In the liver </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (as unchanged drug and as pyrimidine after body storage sites become saturated)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10951005\" class=\"block exp drugH1Div\"><span class=\"drugH1\">Extemporaneous Preparations</span>\n    <p style=\"text-indent:0em;display:inline\">A 100 mg/mL oral suspension may be made with commercially available thiamine powder. Add 10 g of powder to a mortar. Add small portions of a 1:1 mixture of Ora-Sweet&reg; and Ora-Plus&reg; and mix to a uniform paste; mix while adding the vehicle in equal proportions to <b>almost</b> 100 mL; transfer to a calibrated bottle, rinse mortar with vehicle, and add sufficient quantity of vehicle to make 100 mL. Label &quot;shake well&quot;. Stable 91 days under refrigeration or at room temperature.</p>\n    <div class=\"reference\">Ensom MH and Decarie D, &quot;Stability of Thiamine in Extemporaneously Compounded Suspensions,&quot; <i>Can J Hosp Pharm</i>, 2005, 58(1):26-30.</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226740\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Thiamine Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">50 mg (100): $7.02</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Thiamine HCl Injection)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg/mL (2 mL): $8.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Thiamine HCl Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg (100): $5.12</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Vitamin B-1 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg (100): $3.17</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F226742\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Abery (JP);</li>\n      <li>Actamin (JP);</li>\n      <li>AFI-B (NO);</li>\n      <li>Aliaron D 10 (JP);</li>\n      <li>Anerex (MX);</li>\n      <li>Aneurin-AS (DE);</li>\n      <li>Arcavit-B1 (AT);</li>\n      <li>B1-ASmedic (DE);</li>\n      <li>B1-Vicotrat (DE);</li>\n      <li>Becaps (BR);</li>\n      <li>Benerva (AE, AR, BB, BE, BH, BM, BR, BS, BZ, CH, CY, EG, ES, FR, GB, GH, GR, GY, IL, IQ, IR, IT, JM, JO, KE, KW, LB, LU, LY, NL, OM, PE, QA, SA, SE, SR, SY, TT, TZ, UG, YE, ZM);</li>\n      <li>Beneuran (AT);</li>\n      <li>Beneurol (LU);</li>\n      <li>Beneuron (IN);</li>\n      <li>Bermin B (JP);</li>\n      <li>Beta-Sol (AU);</li>\n      <li>Beta-Tabs (AU);</li>\n      <li>Betabion (DE);</li>\n      <li>Betamin (AU);</li>\n      <li>Betamine (LU);</li>\n      <li>Bevitine (FR);</li>\n      <li>Bevitol (AT);</li>\n      <li>Biogen (JP);</li>\n      <li>Dagravit B1 (PT);</li>\n      <li>Dexabion (MX);</li>\n      <li>Hiace (JP);</li>\n      <li>Hithia (JP);</li>\n      <li>Incremin con Hierro (MX);</li>\n      <li>Kirin B1 (JP);</li>\n      <li>Lophakomp-B1 (DE);</li>\n      <li>Metabolin (JP);</li>\n      <li>Mutsutamin (JP);</li>\n      <li>Neo-Panlacticos (MX);</li>\n      <li>Neuramin (FI);</li>\n      <li>Pagavit (MX);</li>\n      <li>Pharmaton (MX);</li>\n      <li>Plivit B1 (HR);</li>\n      <li>Suma-B (MX);</li>\n      <li>Thiamine Injection (AU);</li>\n      <li>Tiamidexal (MX);</li>\n      <li>Tiamin &rdquo;Dak&rdquo; (DK);</li>\n      <li>Tiamina (CO);</li>\n      <li>Tiaminal (MX);</li>\n      <li>Tolima (DE);</li>\n      <li>Tribedoce (MX);</li>\n      <li>Trifosfaneurina (PT);</li>\n      <li>Tyvera (MT);</li>\n      <li>Vit. B1 Agepha (AT);</li>\n      <li>Vita-B1 (FI);</li>\n      <li>Vitamin B1 (HU);</li>\n      <li>Vitamin B1 Jenapharm (DE);</li>\n      <li>Vitamin B1 Kattwiga (DE);</li>\n      <li>Vitamin B1-Hevert (DE);</li>\n      <li>Vitamin B1-Injektopas (DE);</li>\n      <li>Vitamin B1-ratiopharm (DE);</li>\n      <li>Vitamina B1 Biol (AR);</li>\n      <li>Vitaminum B1 (PL);</li>\n      <li>Vitanon[inj.] (JP)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Barennes H, Sengkhamyong K, Ren&eacute; JP, Phimmasane M. Beriberi (thiamine deficiency) and high infant mortality in northern Laos. <i>PLoS Negl Trop Dis</i>. 2015;9(3):e0003581.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-b1-thiamine-pediatric-drug-information/abstract-text/25781926/pubmed\" target=\"_blank\" id=\"25781926\">25781926</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bowman BA, Pfeiffer CM, Barfield WD. Thiamine deficiency, beriberi, and maternal and child health: why pharmacokinetics matter. <i>Am J Clin Nutr</i>. 2013;98(3):635-636.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-b1-thiamine-pediatric-drug-information/abstract-text/23902781 /pubmed\" target=\"_blank\" id=\"23902781 \">23902781 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chiossi G, Neri I, Cavazzuti M, et al, &quot;Hyperemesis Gravidarum Complicated by Wernicke Encephalopathy: Background, Case Report, and Review of the Literature,&quot; <i>Obstet Gynecol Surv</i>, 2006, 61(4):255-68.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-b1-thiamine-pediatric-drug-information/abstract-text/16551377/pubmed\" target=\"_blank\" id=\"16551377\">16551377</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Coats D, Shelton-Dodge K, Ou K, et al. Thiamine deficiency in Cambodian infants with and without beriberi. <i>J Pediatr</i>. 2012;161(5):843-847.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-b1-thiamine-pediatric-drug-information/abstract-text/22703952 /pubmed\" target=\"_blank\" id=\"22703952 \">22703952 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine), <i>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B</i><sub>6</sub><i>, Folate, Vitamin B</i><sub>12</sub><i>, Pantothenic Acid, Biotin and Choline</i>, Washington, DC: National Academy Press, 1998.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kliegman RM, Stanton BMD, St. Geme J, Schor NF, eds. <i>Nelson' s Textbook of Pediatrics</i>. 20th ed. Philadelphia, PA: Saunders Elsevier; 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Thiamine hydrochloride injection [prescribing information]. Rockford, IL: Mylan Institutional LLC; April 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products.<i> Nutr Clin Pract</i>. 2012;27(4):440-491.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-b1-thiamine-pediatric-drug-information/abstract-text/22730042/pubmed\" target=\"_blank\" id=\"22730042\">22730042</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    World Health Organization (WHO). Thiamine deficiency and its prevention and control in major emergencies.1999. Available at http://www.who.int/nutrition/publications/en/thiamine_in_emergencies_eng.pdf</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12833 Version 117.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F226752\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1062567\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F11445204\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1062560\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F226731\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F226717\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1062571\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F226745\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1062570\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F226798\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F226796\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F226737\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F226721\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300131\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6223291\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F226747\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F226728\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F3423333\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Reference Range\" href=\"#F1062569\" class=\"outlineLink\">Reference Range</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F226720\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F226736\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Extemporaneous Preparations\" href=\"#F10951005\" class=\"outlineLink\">Extemporaneous Preparations</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F226740\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F226742\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12833|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=vitamin-b1-thiamine-drug-information\" class=\"drug drug_general\">Vitamin B1 (thiamine): Drug information</a></li><li><a href=\"topic.htm?path=vitamin-b1-thiamine-patient-drug-information\" class=\"drug drug_patient\">Vitamin B1 (thiamine): Patient drug information</a></li></ul></div></div>","javascript":null}